HUP9601331A3 - Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them - Google Patents
Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing themInfo
- Publication number
- HUP9601331A3 HUP9601331A3 HU9601331A HUP9601331A HUP9601331A3 HU P9601331 A3 HUP9601331 A3 HU P9601331A3 HU 9601331 A HU9601331 A HU 9601331A HU P9601331 A HUP9601331 A HU P9601331A HU P9601331 A3 HUP9601331 A3 HU P9601331A3
- Authority
- HU
- Hungary
- Prior art keywords
- homopiperazine
- piperazine
- derivatives
- producing
- pharmaceutical compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9601331A HUP9601331A3 (en) | 1996-05-17 | 1996-05-17 | Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them |
| AU29120/97A AU2912097A (en) | 1996-05-17 | 1997-05-15 | Novel piperazine or homopiperazine derivatives, pharmaceutical compositions containing the same and process for their preparation |
| PCT/HU1997/000020 WO1997044334A2 (en) | 1996-05-17 | 1997-05-15 | Novel piperazine or homopiperazine derivatives, pharmaceutical compositions containing the same and a process for their preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9601331A HUP9601331A3 (en) | 1996-05-17 | 1996-05-17 | Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9601331D0 HU9601331D0 (en) | 1996-07-29 |
| HUP9601331A2 HUP9601331A2 (en) | 1998-09-28 |
| HUP9601331A3 true HUP9601331A3 (en) | 2000-06-28 |
Family
ID=89993978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9601331A HUP9601331A3 (en) | 1996-05-17 | 1996-05-17 | Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2912097A (en) |
| HU (1) | HUP9601331A3 (en) |
| WO (1) | WO1997044334A2 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5859246A (en) * | 1997-01-30 | 1999-01-12 | Neurogen Corporation | 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands |
| US6177566B1 (en) | 1998-06-30 | 2001-01-23 | Neurogen Corporation | 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands |
| CA2336089A1 (en) * | 1998-06-30 | 2000-01-06 | Neurogen Corporation | 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| WO2002004433A2 (en) | 2000-07-06 | 2002-01-17 | Neurogen Corporation | Melanin concentrating hormone receptor ligands |
| ATE374765T1 (en) * | 2000-07-27 | 2007-10-15 | Lilly Co Eli | SUBSTITUTED HETEROCYCLIC AMIDES |
| BR0209932A (en) | 2001-05-22 | 2004-10-13 | Neurogen Corp | Pharmaceutically acceptable compound or salt thereof, pharmaceutical composition, packaged pharmaceutical preparation, methods for modulating mch binding to an mch receptor and mvc, to alter the signal transduction activity of an mch receptor in a cell, to treat a disease or disorder associated with pathogenic obesity mch receptor activation and to determine the presence or absence of mch receptor in a sample, and use of a compound |
| WO2005110982A2 (en) | 2004-04-07 | 2005-11-24 | Neurogen Corporation | Substituted 1-benzyl-4-substituted piperazine analogues |
| EP2149373A1 (en) * | 2008-08-01 | 2010-02-03 | Laboratorios Del. Dr. Esteve, S.A. | 5HT7 receptor ligands and compositions comprising the same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1554897A (en) * | 1976-12-10 | 1979-10-31 | Beecham Group Ltd | (substituted phenyl) - piperazines and their use in pharmaceutical compositions |
| CH643549A5 (en) * | 1979-08-25 | 1984-06-15 | Merz & Co | N- (TRIMETHOXYBENZYL) -N'-PHENYLPIPERAZINE. |
| AU676993B2 (en) * | 1991-06-27 | 1997-04-10 | Virginia Commonwealth University | Sigma receptor ligands and the use thereof |
| EP0556889A1 (en) * | 1992-02-18 | 1993-08-25 | Duphar International Research B.V | Method of preparing aryl(homo)piperazines |
| WO1995004050A1 (en) * | 1993-07-28 | 1995-02-09 | Santen Pharmaceutical Co., Ltd. | Novel 1,4-di(phenylalkyl)piperazine derivative |
| EP0650964A1 (en) * | 1993-11-02 | 1995-05-03 | Duphar International Research B.V | 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives |
-
1996
- 1996-05-17 HU HU9601331A patent/HUP9601331A3/en unknown
-
1997
- 1997-05-15 AU AU29120/97A patent/AU2912097A/en not_active Abandoned
- 1997-05-15 WO PCT/HU1997/000020 patent/WO1997044334A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| HU9601331D0 (en) | 1996-07-29 |
| WO1997044334A3 (en) | 1998-03-12 |
| AU2912097A (en) | 1997-12-09 |
| WO1997044334A2 (en) | 1997-11-27 |
| HUP9601331A2 (en) | 1998-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9601529A3 (en) | Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives, pharmaceutical compositions containing them, process for producing them and their use | |
| HU9700779D0 (en) | Estrogenic agents, process for producing them and pharmaceutical compositions containing them | |
| HU9700777D0 (en) | Estrogenic agents, process for producing them and pharmaceutical compositions containing them | |
| HUP9902850A3 (en) | Quinazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9802565A3 (en) | N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same | |
| HUP9603433A2 (en) | 4-6-diaryl-pyrimidine-derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0003309A3 (en) | Imidazolyl-cyclic acetals, process for producing them and pharmaceutical compositions containing the same | |
| HUP9602511A3 (en) | Aryl-diazinone derivatives, pharmaceutical compositions containing them, and process for producing all these | |
| HUP9802422A3 (en) | Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9700344A3 (en) | Substituted quinazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9603495A2 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation | |
| HUP9701264A3 (en) | Aminoacid derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9900055A3 (en) | 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridin -derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9901739A3 (en) | Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them | |
| HUP0003608A3 (en) | Tetrahydroisoquinoline derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9601034A3 (en) | Aryl-alkyl-pyridazinone compounds, process for producing them, and pharmaceutical compositions containing them | |
| HUP9602681A1 (en) | Hydroxy-pyridinone derivatives, process for producing them and pharmaceutical compositions containing them | |
| HU9503801D0 (en) | Substituted 4-phenyl-thiazol derviatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9800865A3 (en) | Condensed piperidine-derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9701660A3 (en) | 10,13,15-trioxatricyclo[9.2.1.1.9.6]pentadekanon derivatives, process for producing them, and pharmaceutical compositions containing them | |
| HUP9602748A2 (en) | Novel n-pyrimidinyl-sulfonamides, process for producing them and pharmaceutical compositions containing them | |
| HUP9900105A3 (en) | Momopiperazine derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9700989A3 (en) | Ortho-substituted benzoyl-guanidines, process for producing them, and pharmaceutical compositions containing them | |
| HUP0003766A2 (en) | Isoguinolin derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0003997A3 (en) | 3-benzylpiperidine derivatives, pharmaceutical compositions containing them and process for producing them |